Based on the frequency of NKD1 mutation (5%) identified in our cohort of MSI-CRCs, we estimate that NKD1 mutations occur in up to ∼1% of newly diagnosed CRC, or ∼10,000 cases per year. This evidence concerns the gene NKD1 and colorectal carcinoma.